WO2010021514A3 - Pharmaceutical composition containing glutamine for treating atopic dermatitis - Google Patents

Pharmaceutical composition containing glutamine for treating atopic dermatitis Download PDF

Info

Publication number
WO2010021514A3
WO2010021514A3 PCT/KR2009/004672 KR2009004672W WO2010021514A3 WO 2010021514 A3 WO2010021514 A3 WO 2010021514A3 KR 2009004672 W KR2009004672 W KR 2009004672W WO 2010021514 A3 WO2010021514 A3 WO 2010021514A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
atopic dermatitis
glutamine
treating atopic
composition containing
Prior art date
Application number
PCT/KR2009/004672
Other languages
French (fr)
Korean (ko)
Other versions
WO2010021514A2 (en
Inventor
이헌구
조백환
Original Assignee
전북대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 전북대학교 산학협력단 filed Critical 전북대학교 산학협력단
Publication of WO2010021514A2 publication Critical patent/WO2010021514A2/en
Publication of WO2010021514A3 publication Critical patent/WO2010021514A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to a pharmaceutical composition for treating atopic dermatitis containing a glutamine as an active ingredient. According to the present invention, the glutamine is applied on a lesion and attenuates an inflammatory response by suppressing infiltration of inflammatory cells such as leukocytes including eosinophils in the lesion. Thus, edema and pruritus accompanied with an inflammatory response can be relieved and treatment effect is immediately expressed after applying the glutamine.
PCT/KR2009/004672 2008-08-21 2009-08-21 Pharmaceutical composition containing glutamine for treating atopic dermatitis WO2010021514A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2008-0081867 2008-08-21
KR1020080081867A KR100883342B1 (en) 2008-08-21 2008-08-21 Pharmaceutical composition for treatment of atopic dermatitis containing glutamine

Publications (2)

Publication Number Publication Date
WO2010021514A2 WO2010021514A2 (en) 2010-02-25
WO2010021514A3 true WO2010021514A3 (en) 2010-06-24

Family

ID=40681541

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/004672 WO2010021514A2 (en) 2008-08-21 2009-08-21 Pharmaceutical composition containing glutamine for treating atopic dermatitis

Country Status (2)

Country Link
KR (1) KR100883342B1 (en)
WO (1) WO2010021514A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100953900B1 (en) * 2009-08-28 2010-04-22 전북대학교산학협력단 Cosmetic composition for improvement of dermatitis
KR102052509B1 (en) 2019-05-15 2019-12-06 김병천 Composition comprising a culture of Ceriporia lamaritus for preventing of hair loss
KR20200133063A (en) 2019-05-15 2020-11-26 김병천 A cosmetic composition comprising a culture of Ceriporia lamaritus for skin improvement
KR102025611B1 (en) 2019-05-15 2019-11-05 김병천 A composition comprising a culture of Ceriporia lamaritus for preventing or treating of atopic dermatitis
KR20210101707A (en) 2020-02-10 2021-08-19 농업회사법인 주식회사 미드숨비 Composition comprising a fermented lactobacillus salivarius for preventing or improving of atopic dermatitis
CN114028372B (en) * 2021-11-04 2023-09-01 中南大学湘雅医院 Application of glutamine as active ingredient in preparation of psoriasis treatment medicine, psoriasis treatment medicine and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000069015A (en) * 1997-09-19 2000-11-25 카렌 에이. 로우니 Composition and Method for Reducing Stinging in Skin
US20040220137A1 (en) * 2001-07-07 2004-11-04 Gerhard Sauermann Cosmetic and dermatological preparations containing osmolytes for the treatment of and active prevention of dry skin and of other negative alterations in the physiological homeostasis of healthy skin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000069015A (en) * 1997-09-19 2000-11-25 카렌 에이. 로우니 Composition and Method for Reducing Stinging in Skin
US20040220137A1 (en) * 2001-07-07 2004-11-04 Gerhard Sauermann Cosmetic and dermatological preparations containing osmolytes for the treatment of and active prevention of dry skin and of other negative alterations in the physiological homeostasis of healthy skin

Also Published As

Publication number Publication date
WO2010021514A2 (en) 2010-02-25
KR100883342B1 (en) 2009-02-11

Similar Documents

Publication Publication Date Title
WO2010021514A3 (en) Pharmaceutical composition containing glutamine for treating atopic dermatitis
WO2012026766A3 (en) Novel heterocyclic compound, and composition for treating inflammatory diseases using same
WO2013177594A3 (en) Xylitol-based anti-mucosal compositions and related methods and compositions
WO2011156030A3 (en) High oil-content emollient aerosol foam compositions
MX340250B (en) Emollient foams for treatment of dermatoses.
WO2014062691A3 (en) Compositions for modulating c9orf72 expression
WO2008001240A3 (en) Transdermal delivery of oleocanthal for relief of inflammation
WO2011158042A3 (en) Ureido- pyrazole derivatives for use in the treatment of rhinovirus infections
UA99654C2 (en) Method for controlling harmful plants, herbicidal composition and a method to reduce volatility of clomazone
WO2010015929A3 (en) Uses of mesenchymal stem cells
WO2008098192A3 (en) Compositions and methods for treating neuropathy
WO2013178965A3 (en) Active ingredients activating mitophagy in skin cells and use of same for improving skin condition
WO2010048087A3 (en) Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
WO2011085162A3 (en) Topical transdermal dexmedetomidine compositions and methods of use thereof
WO2010033977A3 (en) Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
WO2012157978A3 (en) Daphne genkwa extracts, and pharmaceutical composition containing fractions of the extracts or compounds separated from the extracts as active ingredients for preventing or treating atopic dermatitis
WO2011049327A3 (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
DK2714888T3 (en) RECOMBINANT DO
WO2010032011A8 (en) Anti-fungal therapy
SA113340494B1 (en) Composition for treating metabolic disorders
WO2011119247A3 (en) Topical skincare composition
WO2012067460A3 (en) Method for screening for materials for promoting the differentiation of skin cells
WO2013012197A3 (en) Composition for preventing or alleviating skin wrinkles containing honeybush extract or a fermented liquor thereof as an active ingredient
WO2010127197A3 (en) Method and composition for treating diabetic ketoacidosis
WO2019004738A3 (en) Use of composition comprising adipose stem cell-derived exosome as effective ingredient in alleviating dermatitis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09808418

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09808418

Country of ref document: EP

Kind code of ref document: A2